Two USC stem cell researchers have received a combined $4 million from the National Institute of Health (NIH). Dr. Qi-Long Ying will oversee a $1.32 million grant focusing on how two specific proteins influence whether stem cells self-renew to produce additional stem cells or become more specialized cell types. A $2.82 million grant awarded to Dr. Neil Segil will explore why humans are unable to recover from hearing loss, while birds and reptiles can.Read More
Science Market Update
Tags: CA, University of Southern California, California, USC, Southwest Region, stem cell research market, Biotech Vendor Showcase, laboratory suppliers, New research center, stem cell science, Biotech Showcase 2018
UC Davis Medical Center is home to one of only 49 National Cancer Institute (NCI) designated comprehensive cancer centers. The UC Davis Center is the only comprehensive cancer center in California’s Central Valley and inland northern California. It serves a region with a population of roughly 6 million people. The Center has $63 million in NHI and California Healthcare Institute funding.
The NCI, a division of the NIH, awards University of California, Davis roughly $200 million annually to conduct cancer research.
Here are the top 5 NCI grants this year:
Tags: CA, University of California Davis Medical Center, Southwest, NIH funded Research Projects, UCDMC, BioResearch Product Faire Event, biotech vendor show, Sacramento, cancer research funding, Comprehensive Cancer Center, Oncology, Cancer Immunotherapy, Cancer Science
Two UCLA research programs have earned state and federal grants totaling $18.8 million, while two departments have been given $3.35 million in private endowments, according to university news reports. The Urology Department received $9.3 million from the state of California while the Fielding School of Public Health earned a $9.5 million grant from the National Institute of Drug Abuse (NIDA).Read More
Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, cancer reserach, UCLA research funding, HIV research, Prostate cancer research, nih research funding
An estimated 15 million Americans will develop Alzheimer’s disease by 2060, according to researchers at the UCLA Fielding School of Public Health. The December 2017 study is the first of its kind to estimate the numbers of Americans with preclinical Alzheimer’s disease.
Tags: CA, UCLA School of Public Health, new research funding, Alzheimer's Research, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, Alzheimer's research market, UCLA research funding, cytomegalovirus, Geriatrics
UC San Diego’s Geriatric Emergency Room has received a Level 1 designation, the highest and most comprehensive level of accreditation awarded by the American College of Emergency Physicians (ACEP). Located on the La Jolla campus, it is California’s first geriatric emergency room. It is one of eight geriatric ERs in the U.S. to earn accreditation.Read More
Tags: CA, University of California San Diego, new medical facility, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, new medical buildings, 2018, life sciecne, san diego research, Emergency Medicine, cbd
UC San Diego’s new outpatient pavilion, which opened in March of this year, has been named the Koman Family Outpatient Clinic in tribute to Bill and Amy Koman and their family. The cancer research advocates have raised millions for the La Jolla campus’ medical facilities over the past 18 years.Their philanthropic efforts have focused on supporting collaborative cancer research at Moores Cancer Center at UC San Diego Health, Salk Institute, Sanford-Burnham Prebys Medical Center and Rady Children’s Hospital, San Diego and now the outpatient pavilion. The couple founded the Padres Pedal the Cause, an annual cycling event that raised $20 million between its inception in 2010 and 2016, according to an article in Ranch & Coast Magazine.Read More
Tags: CA, University of California San Diego, new medical facility, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, new medical buildings, cancer reserach, 2018, life sciecne, san diego research, new science buildings
Researchers at the University of California San Diego School of Medicine are hopeful the combination of the experimental drug cirmtuzumab along with ibrutinub can halt the progression of chronic B-cell cancers. In an article published in the June 1 issue of Cell Stem Cell, researchers reported that treatment of 26 chronic leukemia patients with the experimental drug combination appeared to stop the disease’s progress.Read More
Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, cancer reserach, 2018, life sciecne, Blood Cancer, san diego research
UC San Diego has received federal support to continue its efforts to develop new treatments and, ultimately, find a cure for HIV/AIDS. A five-year, $15 million grant has been awarded to the university’s Center for AIDS Research by the National Institute of Allergy and Infectious Diseases (NIAID). The grant signals the federal agency’s support of the university’s research efforts that started in 1994, the height of the AIDS epidemic.Read More
Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, NIH grant, 2018, life sciecne, nih research funding, san diego research
UC Davis School of Medicine in Sacramento ranked in the top 20 percent of national medical schools for research funding by the National Institute of Health (NIH). According to the 2017 report issued by the Blue Ridge Institute for Medical Research, the school received $176 million to fund 356 grant proposals last year. This placed UC Davis at 26th in the nation for NIH funding.